【漸凍症】《insitro》獲得2,500萬美元里程碑付款，用於驗證「漸凍症」 第一個新穎基因靶點

 【漸凍症】《insitro》獲得2,500萬美元里程碑付款，用於驗證「漸凍症(ALS)」 第一個新穎基因靶點

 文章出處  

Businesswire 

 

 原文標題  

insitro Receives $25 Million in Milestone Payments from Bristol Myers Squibb for the Achievement of Discovery Milestones and the Selection of First Novel Genetic Target for ALS 

 

 Twitter  

https://x.com/aimedadviser/status/1869711121025995146 

 

 文章序號  

6882 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.